By: Harold Brubaker
For years, the Pennsylvania Department of Health allowed the state’s medical marijuana companies to sell hundreds of medicines that the agency now considers potentially unsafe.
Something changed in November when regulators started a process that led last month to a massive recall and ban of 670 types of cannabis concentrates for vaping — $12 million worth — that they had previously approved for sale in Pennsylvania’s roughly 150 marijuana dispensaries.
Subscribe and stay updated
Receive our latest blog posts by email.
